Use of Natural Products as Chemical Library for Drug Discovery and Network Pharmacology

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Gu, Jiangyong ^a   Gui, Yuanshen ^a,b   Chen, Lirong ^a   Yuan, Gu ^a   Lu, Hui Zhe ^a,b   Xu, Xiaojie ^a  

^a PEKING UNIVERSITY   (China)

^b CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALEDONINE; GENISTEIN; LYCOPODIUM BASE A; LYCOPODIUM BASE B; NATURAL PRODUCT; ORMOJINE; ORMOSININ; QUERCETIN; SELDOMYCIN 5; STAUROSPORINE; STRYCHNOHEXAMINE; UNCLASSIFIED DRUG; VATAMIDINE; VATAMINE; VATINE; BIOLOGICAL PRODUCT;

ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; DRUG APPROVAL; DRUG INDICATION; DRUG TARGETING; FOOD AND DRUG ADMINISTRATION; HIGH THROUGHPUT SCREENING; MOLECULAR DOCKING; MOLECULAR LIBRARY; MOLECULAR MODEL; NETWORK PHARMACOLOGY; PHARMACOLOGICAL PARAMETERS; PHYSICAL CHEMISTRY; POLYPHARMACY; PREDICTION; PRODUCT DEVELOPMENT; PROTEIN TARGETING; BIOLOGY; DISEASES; DRUG DATABASE; DRUG DEVELOPMENT; LEGISLATION AND JURISPRUDENCE; PHARMACOLOGY; PROCEDURES; UNITED STATES;

BIOLOGICAL PRODUCTS; COMPUTATIONAL BIOLOGY; DATABASES, PHARMACEUTICAL; DISEASE; DRUG APPROVAL; DRUG DISCOVERY; PHARMACOLOGY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84876736739     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062839     Document Type: Article

References (62)

1. Newman DJ, Cragg GM, (2012) Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010. Journal of Natural Products 75: 311-335.
2. Ji HF, Li XJ, Zhang HY, (2009) Natural products and drug discovery Can thousands of years of ancient medical knowledge lead us to new and powerful drug combinations in the fight against cancer and dementia? Embo Reports 10: 194-200.
3. Harvey A, (2008) Natural products in drug discovery. Drug Discovery Today 13: 894-901.
4. Kingston DGI, (2011) Modern Natural Products Drug Discovery and Its Relevance to Biodiversity Conservation. Journal of Natural Products 74: 496-511.
5. Chin YW, Balunas MJ, Chai HB, Kinghorn AD, (2006) Drug discovery from natural sources. The AAPS Journal 8: E239-E253.
6. Lagunin A, Filimonov D, Poroikov V, (2010) Multi-Targeted Natural Products Evaluation Based on Biological Activity Prediction with PASS. Current Pharmaceutical Design 16: 1703-1717.
7. Clardy J, Walsh C, (2004) Lessons from natural molecules. Nature 432: 829-837.
8. Gu J, Zhang H, Chen L, Xu S, Yuan G, et al. (2011) Drug-target network and polypharmacology studies of a Traditional Chinese Medicine for type II diabetes mellitus. Computational Biology and Chemistry 35: 293-297.
9. Vogt I, Mestres J, (2010) Drug-Target Networks. Molecular Informatics 29: 10-14.
10. Yildirim MA, Goh KI, Cusick ME, Barabasi AL, Vidal M, (2007) Drug-target network. Nature Biotechnology 25: 1119-1126.
11. Wang XJ, Wei XM, Thijssen B, Das J, Lipkin SM, et al. (2012) Three-dimensional reconstruction of protein networks provides insight into human genetic disease. Nature Biotechnology 30: 159-164.
12. Yang K, Ma WZ, Liang HH, Qi OY, Tang C, et al. (2007) Dynamic simulations on the arachidonic acid metabolic network. Plos Computational Biology 3: 523-530.
13. Zhang Y, Thiele I, Weekes D, Li ZW, Jaroszewski L, et al. (2009) Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science 325: 1544-1549.
14. Li QA, Li XD, Li CH, Chen LR, Song J, et al. (2011) A Network-Based Multi-Target Computational Estimation Scheme for Anticoagulant Activities of Compounds. Plos One 6.
15. Hong JY, (2011) Role of natural product diversity in chemical biology. Current Opinion in Chemical Biology 15: 350-354.
16. Firn RD, Jones CG, (2003) Natural products- a simple model to explain chemical diversity. Natural Product Reports 20: 382-391.
17. Basso LA, da Silva LHP, Fett-Neto AG, Junior WFD, Moreira ID, et al. (2005) The use of biodiversity as source of new chemical entities against defined molecular targets for treatment of malaria, tuberculosis, and T-cell mediated diseases- A Review. Memorias Do Instituto Oswaldo Cruz 100: 575-606.
18. Quinn RJ, Carroll AR, Pham NB, Baron P, Palframan ME, et al. (2008) Developing a drug-like natural product library. Journal of Natural Products 71: 464-468.
19. Feher M, Schmidt JM, (2003) Property distributions: Differences between drugs, natural products, and molecules from combinatorial chemistry. Journal of Chemical Information and Computer Sciences 43: 218-227.
20. Yongye AB, Waddell J, Medina-Franco JL, (2012) Molecular scaffold analysis of natural products databases in the public domain. Chemical Biology & Drug Design 80: 717-724.
21. Grabowski K, Baringhaus KH, Schneider G, (2008) Scaffold diversity of natural products: inspiration for combinatorial library design. Natural Product Reports 25: 892-904.
22. Lee ML, Schneider G, (2001) Scaffold architecture and pharmacophoric properties of natural products and trade drugs: Application in the design of natural product-based combinatorial libraries. Journal of Combinatorial Chemistry 3: 284-289.
23. Dobson CM, (2004) Chemical space and biology. Nature 432: 824-828.
24. Rosen J, Gottfries J, Muresan S, Backlund A, Oprea TI, (2009) Novel Chemical Space Exploration via Natural Products. Journal of Medicinal Chemistry 52: 1953-1962.
25. Grabowski K, Schneider G, (2007) Properties and Architecture of Drugs and Natural Products Revisited. Current Chemical Biology 1: 115-127.
26. Henkel T, Brunne RM, Muller H, Reichel F, (1999) Statistical investigation into the structural complementarity of natural products and synthetic compounds. Angewandte Chemie-International Edition 38: 643-647.
27. Qiao XB, Hou TJ, Zhang W, Guo SL, Xu XJ, (2002) A 3D structure database of components from Chinese traditional medicinal herbs. Journal of Chemical Information and Computer Sciences 42: 481-489.
28. Shen JH, Xu XY, Cheng F, Liu H, Luo XM, et al. (2003) Virtual screening on natural products for discovering active compounds and target information. Current Medicinal Chemistry 10: 2327-2342.
29. He M, Yan XJ, Zhou JJ, Xie GR, (2001) Traditional Chinese medicine database and application on the Web. Journal of Chemical Information and Computer Sciences 41: 273-277.
30. O'Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, et al. (2011) Open Babel: An open chemical toolbox. Journal of Cheminformatics 3.
31. Yap CW, (2011) PaDEL-Descriptor: An Open Source Software to Calculate Molecular Descriptors and Fingerprints. Journal of Computational Chemistry 32: 1466-1474.
32. Liu TQ, Lin YM, Wen X, Jorissen RN, Gilson MK, (2007) BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities. Nucleic Acids Research 35: D198-D201.
33. Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T, (2011) Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 27: 431-432.
34. Junker BH, Koschutzki D, Schreiber F, (2006) Exploration of biological network centralities with CentiBiN. Bmc Bioinformatics 7: 219.
35. Jiang XH, Kumar K, Hu X, Wallqvist A, Reifman J (2008) DOVIS 2.0: an efficient and easy to use parallel virtual screening tool based on AutoDock 4.0. Chemistry Central Journal 2.
36. Knox C, Law V, Jewison T, Liu P, Ly S, et al. (2011) DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs. Nucleic Acids Research 39: D1035-D1041.
37. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ, (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews 23: 3-25.
38. Faller B, Ottaviani G, Ertl P, Berellini G, Collis A, (2011) Evolution of the physicochemical properties of marketed drugs: can history foretell the future? Drug Discovery Today 16: 976-984.
39. Leeson P, (2012) Drug discovery: Chemical beauty contest. Nature 481: 455-456.
40. Leeson PD, Springthorpe B, (2007) The influence of drug-like concepts on decision-making in medicinal chemistry. Nature Reviews Drug Discovery 6: 881-890.
41. Bade R, Chan H-F, Reynisson J, (2010) Characteristics of known drug space. Natural products, their derivatives and synthetic drugs. European Journal of Medicinal Chemistry 45: 5646-5652.
42. Mirza A, Desai R, Reynisson J, (2009) Known drug space as a metric in exploring the boundaries of drug-like chemical space. European Journal of Medicinal Chemistry 44: 5006-5011.
43. Bickerton GR, Paolini GV, Besnard J, Muresan S, Hopkins AL, (2012) Quantifying the chemical beauty of drugs. Nature Chemistry 4: 90-98.
44. Lipinski C, Hopkins A, (2004) Navigating chemical space for biology and medicine. Nature 432: 855-861.
45. Lopez-Vallejo F, Giulianotti MA, Houghten RA, Medina-Franco JL, (2012) Expanding the medicinally relevant chemical space with compound libraries. Drug Discovery Today 17: 718-726.
46. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, et al. (2012) ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Research 40: D1100-D1107.
47. Zhang M, Deng J, Fang CV, Zhang X, Lu LJ (2010) Molecular Network Analysis and Applications. Knowledge-Based Bioinformatics: John Wiley & Sons, Ltd. 251-287.
48. Omura S, Iwai Y, Hirano A, Nakagawa A, Awaya J, et al. (1977) New Alkaloid Am-2282 of Streptomyces Origin Taxonomy, Fermentation, Isolation and Preliminary Characterization. Journal of Antibiotics 30: 275-282.
49. Wang YF, Yin OQR, Graf P, Kisicki JC, Schran H, (2008) Dose- and time-dependent pharmacokinetics of midostaurin in patients with diabetes mellitus. Journal of Clinical Pharmacology 48: 763-775.
50. Gani OABSM, Engh RA, (2010) Protein kinase inhibition of clinically important staurosporine analogues. Natural Product Reports 27: 489-498.
51. Wu LL, Yang XB, Huang ZM, Liu HZ, Wu GX, (2007) In vivo and in vitro antiviral activity of hyperoside extracted from Abelmoschus manihot (L) medik. Acta Pharmacologica Sinica 28: 404-409.
52. Yu YB, Miyashiro H, Nakamura N, Hattori M, Park JC, (2007) Effects of triterpenoids and flavonoids isolated from Alnus firma on HIV-1 viral enzymes. Archives of Pharmacal Research 30: 820-826.
53. Davis JM, Murphy EA, Carmichael MD, Davis B, (2009) Quercetin increases brain and muscle mitochondrial biogenesis and exercise tolerance. American Journal of Physiology-Regulatory Integrative and Comparative Physiology 296: R1071-R1077.
54. Verschoyle RD, Steward WP, Gescher AJ, (2007) Putative cancer chemopreventive agents of dietary origin- How safe are they? Nutrition and Cancer-an International Journal 59: 152-162.
55. Gibellini L, Pinti M, Nasi M, Montagna JP, De Biasi S, et al. (2011) Quercetin and Cancer Chemoprevention. Evidence-Based Complementary and Alternative Medicine: 1-15.
56. Das A, Banik NL, Ray SK, (2010) Flavonoids Activated Caspases for Apoptosis in Human Glioblastoma T98G and U87MG Cells But Not in Human Normal Astrocytes. Cancer 116: 164-176.
57. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, et al. (2009) AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility. Journal of Computational Chemistry 30: 2785-2791.
58. Hopkins AL, (2007) Network pharmacology. Nature Biotechnology 25: 1110-1111.
59. Hopkins AL, (2008) Network pharmacology: the next paradigm in drug discovery. Nature Chemical Biology 4: 682-690.
60. Hoeng J, Deehan R, Pratt D, Martin F, Sewer A, et al. (2012) A network-based approach to quantifying the impact of biologically active substances. Drug Discovery Today 17: 413-418.
61. Doman TN, McGovern SL, Witherbee BJ, Kasten TP, Kurumbail R, et al. (2002) Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B. Journal of Medicinal Chemistry 45: 2213-2221.
62. Zhu F, Shi Z, Qin C, Tao L, Liu X, et al. (2012) Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. Nucleic Acids Research 40: D1128-D1136.